ALKERMES | ALKS - 流动负债

股票价格

33.31

每天变化

-0.60 -1.77%

每月一次

13.42%

每年

19.65%

Q2 预测

32.32

金融业

USD

USD 2.49B

现金及等价物

USD 388.57M

USD 46.21M

USD 1.93B

USD 543.44M

USD 71.6M

股息收益率

0

USD -10.95M

USD 100.31M

1.8K

EPS每股收益

USD 0.29

股本和储备

USD 1.82B

USD 338.34M

债务利息支出

USD 12.28M

USD 11.94M

USD 285.82M

USD 5.49B

USD 49.34M

USD 326.44M

USD -10.95M

普通股股本

USD 165.61M

19.54

USD 100.74M

USD 384.5M

销售和管理费用

USD 187.2M

USD 196.63M

贸易债权人

USD 107.95M

应收帐款人

USD 334.03M

	流动负债	更改		日
AbbVie	USD 43.29B		3.9B	2025-12
Acadia Pharmaceuticals	USD 277.11M		79.47M	2025-12
ALKERMES	USD 543.44M		69.08M	2025-12
Amgen	USD 25.49B		3.7B	2025-12
Biogen	USD 3.35B		59.4M	2025-12
BioMarin Pharmaceutical	USD 759.03M		39.41M	2025-12
Bristol-Myers Squibb	USD 28.14B		608M	2025-09
Coherus Biosciences	USD 140.39M		231.91M	2025-12
Eli Lilly	USD 35.23B		4.91B	2025-12
Gilead Sciences	USD 11.81B		485M	2025-12
Heron Therapeutics	USD 96.1M		6.39M	2025-12
Ionis Pharmaceuticals	USD 783M		120.46M	2025-12
J&J	USD 57.72B		3.59B	2026-03
Malin Corporation	EUR 1000K		500K	2024-12
Merck	USD 28.63B		2.59B	2025-09
Minerva Neurosciences	USD 2.29M		381K	2025-12
Nektar Therapeutics	USD 53.54M		12.8M	2025-12
Neurocrine Biosciences	USD 743.4M		105.4M	2025-12
Otsuka Holdings	JPY 749.11B		50.84B	2025-12
Ovoca Bio	EUR 186K		2.26M	2025-06
Pfizer	USD 36.6B		1.13B	2025-09
Regeneron Pharmaceuticals	USD 4.37B		56.7M	2025-12
Vertex Pharmaceuticals	USD 3.86B		614.1M	2025-12